About us2020-06-30T12:55:12+00:00

About us

Cimon Medical AS is based on groundbreaking, patented technology originating from the internationally renowned ultrasound environment at The Norwegian University of Science and Technology (NTNU) and St. Olavs University Hospital (St. Olavs), both located in Trondheim, Norway.

The technology is invented by Professor Hans Torp, a driving force in the Trondheim ultrasound community. Together with co-founder and pediatrician, Siri Ann Nyrnes, they established the vision to apply this technology for continuous monitoring of cerebral blood-flow in neonates. To reduce neonatal mortality and the risk of neurodevelopmental damage, there is a strong need for improved monitoring of brain circulation during birth, resuscitation and intensive care treatment, but currently no adequate solution is available.

The company’s vision is to develop products for a wide range of clinical applications related to continuous monitoring of blood-flow, with NeoDoppler as the first product.


  • 1976 – 2015
    Doppler Ultrasound for clinical use is developed at the internationally renowned Department of Circulation and Imaging at the Norwegian Technical University NTNU) in Trondheim, Norway
  • 2015 – 2017
    Idea and concept for Cimon technology developed by Prof. Hans Torp
  • 2017 – 2019
    Pilot- and clinical studies with prototypes initiated at St.Olavs and Oslo Univ. Hospital
  • 2020
    Industrialization process with selected manufacturing partners
  • Q4 2021
    Launch of 1st regulatory approved product – NeoDoppler

Winner – DNB Healtchare Prize 2019

Winner – Newcomer of the year 2019
Winner – Establishment Scholarship 2019


Dr. Tormod Thomsen, PhD – CEO

20 years of experience from medical technology and healthcare related industry as founder; CEO and other management positions. Extensive experience in product development, international business development, sales and marketing.

Prof. Hans Torp – Inventor

Professor in medical technology at the Department of Circulation and Medical Imaging, NTNU. More than 40 years of experience in research and development of ul- trasound Doppler technology and have received several awards for his work.

Magne Gudmundsen – Chief Software Architect

Experienced full-stack software developer and architect from multiple start-up companies, with a strong user focus. Have led development of medical software applications to CE and FDA approval.

Dr. Siri Ann Nyrnes, MD, Phd – Medical Advisor

Consultant pediatric cardiologist at the pediatric department, St. Olavs hospital and researcher at the Department of Circulation and Medical Imaging, NTNU. Project leader of the NeoDoppler research, responsible for the clinical verification.

Dr. Torbjørn Hergum, Phd – System Specialist

15 years of experience from Research and Development of ultrasound Doppler systems, starting with a PhD on 3D Doppler ultrasound for leaky heart valves. Several Doppler-related patents and patents pending. Ultrasound Systems specialist with detailed knowledge of the full ultrasound stack, from acoustics through hardware, signal processing and applications. Co-Inventor of the core technology patent of Cimon.

Dr. Geir Holom, MD, Phd – Business Dev.

Experienced hospital clinician and medical researcher. Background also includes work in management consulting and finance, as well as advising medtech startups

Mårten Wigstøl – Chairman of the Board

Senior executive from diagnostic and med.Tech. Versatile transaction and financing experience including IPO’s, private placements, M&As and sale of several companies. Professional Board Member, investor, co-founder and consultant in a broad range of startup-companies.

Our partners

St.Olavs Hospital collaborates closely with NTNU on education and has a special responsibility for sharing knowledge and supporting professional development in the specialist health services in central Norway.

The regional hospital is responsible for the most specialized treatment services, and therefore has patients throughout central Norway. St. Olavs Hospital also has some national functions and collaborates with other university hospitals.

NTNU is Norway’s university for higher ed- ucation in technology and natural sciences.

NTNU has 9 faculties and 55 institutes and more than 100 laboratories. The university employs approximately 5360 academic staff and has 40 000 students.

The university is recognized for a broad cooperation with national and international businesses and has an annual budget of approx. 9 billion Norwegian kroner.

NTNU Technology Transfer AS works to create value from research based ideas that come out of The Norwegian University of Science and Technology (NTNU) and The Central Norway Regional Health Authority (Helse Midt-Norge).

NTNU Technology Transfers goal is to create benefit to society from these ideas in the form of new products, new services, new industries and new jobs.